Symbol:
Ifitm3
Name:
interferon induced transmembrane protein 3
RGD ID:
1595844
Description:
Involved in cardiac muscle cell differentiation. Predicted to be located in several cellular components, including bounding membrane of organelle; cell surface; and endoplasmic reticulum. Predicted to be part of protein-containing complex. Human ortholog(s) of this gene implicated in COVID-19. Orthologous to several human genes including IFITM3 (interferon induced transmembrane protein 3); INTERACTS WITH 1-naphthyl isothiocyanate; 17alpha-ethynylestradiol; 17beta-estradiol.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
dispanin subfamily A member 2b; DSPA2b; interferon-induced transmembrane protein 3; interferon-inducible protein; interferon-inducible protein variant 10; rat8
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Related Pseudogenes:
Ifitm3-ps2
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 205,540,649 - 205,541,758 (-) NCBI GRCr8 mRatBN7.2 1 196,111,026 - 196,112,135 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 196,111,043 - 196,112,203 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 1 204,456,782 - 204,457,903 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 1 211,583,367 - 211,584,488 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 1 204,257,495 - 204,258,616 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 1 213,810,712 - 213,811,821 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 213,810,696 - 213,811,901 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 220,730,715 - 220,731,824 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 201,198,659 - 201,199,768 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 1 193,745,524 - 193,746,633 (-) NCBI Celera Cytogenetic Map 1 q41 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Ifitm3 Rat (-)-epigallocatechin 3-gallate decreases expression ISO IFITM3 (Homo sapiens) 6480464 epigallocatechin gallate results in decreased expression of IFITM3 mRNA CTD PMID:32512070 and PMID:35701726 Ifitm3 Rat (1->4)-beta-D-glucan multiple interactions ISO Ifitm3 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IFITM3 mRNA CTD PMID:36331819 Ifitm3 Rat 1,2-dichloroethane decreases expression ISO Ifitm3 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of IFITM3 mRNA CTD PMID:28960355 Ifitm3 Rat 1,2-dimethylhydrazine increases expression ISO Ifitm3 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of IFITM3 mRNA CTD PMID:22206623 Ifitm3 Rat 1,2-dimethylhydrazine multiple interactions ISO Ifitm3 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of IFITM3 mRNA] CTD PMID:22206623 Ifitm3 Rat 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of IFITM3 mRNA CTD PMID:30723492 Ifitm3 Rat 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of IFITM3 mRNA CTD PMID:17557909 Ifitm3 Rat 17beta-estradiol increases expression ISO Ifitm3 (Mus musculus) 6480464 Estradiol results in increased expression of IFITM3 mRNA CTD PMID:19484750 Ifitm3 Rat 17beta-estradiol decreases expression ISO Ifitm3 (Mus musculus) 6480464 Estradiol results in decreased expression of IFITM3 mRNA CTD PMID:39298647 Ifitm3 Rat 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of IFITM3 mRNA CTD PMID:32145629 Ifitm3 Rat 17beta-estradiol multiple interactions ISO IFITM3 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of IFITM3 mRNA CTD PMID:30165855 Ifitm3 Rat 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO Ifitm3 (Mus musculus) 6480464 2 more ... CTD PMID:30294300 Ifitm3 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO IFITM3 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of IFITM3 mRNA CTD PMID:22574217 Ifitm3 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of IFITM3 mRNA CTD PMID:34747641 Ifitm3 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ifitm3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of IFITM3 mRNA CTD PMID:21570461 and PMID:26377647 Ifitm3 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of IFITM3 mRNA CTD PMID:21215274 and PMID:33387578 Ifitm3 Rat 2,4,6-trinitrobenzenesulfonic acid increases expression ISO Ifitm3 (Mus musculus) 6480464 Trinitrobenzenesulfonic Acid results in increased expression of IFITM3 mRNA CTD PMID:17982090 Ifitm3 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Ifitm3 (Mus musculus) 6480464 2 more ... CTD PMID:38648751 Ifitm3 Rat 3,4-dichloroaniline increases expression EXP 6480464 3 and 4-dichloroaniline results in increased expression of IFITM3 mRNA CTD PMID:24172598 Ifitm3 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO IFITM3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of IFITM3 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of IFITM3 mRNA CTD PMID:28628672 Ifitm3 Rat 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1 and 2-dithiol-3-thione results in decreased expression of IFITM3 mRNA CTD PMID:19162173 Ifitm3 Rat 4,4'-sulfonyldiphenol increases expression ISO Ifitm3 (Mus musculus) 6480464 bisphenol S results in increased expression of IFITM3 mRNA CTD PMID:30951980 Ifitm3 Rat 4,4'-sulfonyldiphenol affects expression ISO Ifitm3 (Mus musculus) 6480464 bisphenol S affects the expression of IFITM3 mRNA CTD PMID:39298647 Ifitm3 Rat 5-aza-2'-deoxycytidine increases expression ISO IFITM3 (Homo sapiens) 6480464 Decitabine results in increased expression of IFITM3 mRNA CTD PMID:19151715 Ifitm3 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of IFITM3 mRNA CTD PMID:24780913 Ifitm3 Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of IFITM3 mRNA CTD PMID:31881176 Ifitm3 Rat all-trans-retinoic acid increases expression ISO IFITM3 (Homo sapiens) 6480464 Tretinoin results in increased expression of IFITM3 mRNA CTD PMID:23724009 and PMID:33167477 Ifitm3 Rat all-trans-retinoic acid multiple interactions ISO Ifitm3 (Mus musculus) 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of IFITM3 mRNA CTD PMID:30951980 Ifitm3 Rat amitrole increases expression EXP 6480464 Amitrole results in increased expression of IFITM3 mRNA CTD PMID:38685447 Ifitm3 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of IFITM3 mRNA CTD PMID:16483693 Ifitm3 Rat antimycin A decreases expression ISO IFITM3 (Homo sapiens) 6480464 Antimycin A results in decreased expression of IFITM3 mRNA CTD PMID:33512557 Ifitm3 Rat antirheumatic drug decreases expression ISO IFITM3 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of IFITM3 mRNA CTD PMID:24449571 Ifitm3 Rat aristolochic acid A increases expression ISO IFITM3 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of IFITM3 mRNA CTD PMID:33212167 Ifitm3 Rat arsenous acid increases expression ISO IFITM3 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of IFITM3 mRNA CTD PMID:20458559 Ifitm3 Rat azoxystrobin decreases expression ISO IFITM3 (Homo sapiens) 6480464 azoxystrobin results in decreased expression of IFITM3 mRNA CTD PMID:33512557 Ifitm3 Rat benzo[a]pyrene decreases expression ISO Ifitm3 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of IFITM3 mRNA CTD PMID:19770486 Ifitm3 Rat benzo[a]pyrene multiple interactions ISO Ifitm3 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of IFITM3 mRNA and [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of IFITM3 protein CTD PMID:26271895 Ifitm3 Rat benzoates decreases expression ISO IFITM3 (Homo sapiens) 6480464 Benzoates analog results in decreased expression of IFITM3 mRNA CTD PMID:29472718 Ifitm3 Rat beta-naphthoflavone decreases expression ISO IFITM3 (Homo sapiens) 6480464 beta-Naphthoflavone results in decreased expression of IFITM3 mRNA CTD PMID:32858204 Ifitm3 Rat bis(2-ethylhexyl) phthalate increases expression ISO Ifitm3 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of IFITM3 mRNA CTD PMID:33162236 Ifitm3 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of IFITM3 mRNA CTD PMID:25181051 and PMID:30903817 Ifitm3 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of IFITM3 mRNA CTD PMID:32145629 and PMID:34947998 Ifitm3 Rat bisphenol A decreases expression ISO IFITM3 (Homo sapiens) 6480464 bisphenol A results in decreased expression of IFITM3 mRNA CTD PMID:38568856 Ifitm3 Rat bisphenol A increases expression ISO Ifitm3 (Mus musculus) 6480464 bisphenol A results in increased expression of IFITM3 mRNA CTD PMID:30951980 and PMID:32156529 Ifitm3 Rat bisphenol A multiple interactions ISO IFITM3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of IFITM3 mRNA CTD PMID:28628672 Ifitm3 Rat bisphenol F multiple interactions ISO IFITM3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of IFITM3 mRNA CTD PMID:28628672 Ifitm3 Rat bisphenol F increases expression ISO Ifitm3 (Mus musculus) 6480464 bisphenol F results in increased expression of IFITM3 mRNA CTD PMID:30951980 Ifitm3 Rat bisphenol F multiple interactions ISO Ifitm3 (Mus musculus) 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of IFITM3 mRNA CTD PMID:30951980 Ifitm3 Rat cadmium atom increases expression ISO IFITM3 (Homo sapiens) 6480464 Cadmium results in increased expression of IFITM3 mRNA CTD PMID:24376830 Ifitm3 Rat cadmium dichloride decreases expression ISO IFITM3 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of IFITM3 mRNA CTD PMID:21457566 Ifitm3 Rat cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of IFITM3 mRNA CTD PMID:25993096 Ifitm3 Rat captan decreases expression ISO Ifitm3 (Mus musculus) 6480464 Captan results in decreased expression of IFITM3 mRNA CTD PMID:31558096 Ifitm3 Rat carbon nanotube increases expression ISO Ifitm3 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 Ifitm3 Rat chlordecone increases expression ISO Ifitm3 (Mus musculus) 6480464 Chlordecone results in increased expression of IFITM3 mRNA CTD PMID:33711761 Ifitm3 Rat chloropicrin decreases expression ISO IFITM3 (Homo sapiens) 6480464 chloropicrin results in decreased expression of IFITM3 mRNA CTD PMID:26352163 Ifitm3 Rat chlorpyrifos increases expression ISO Ifitm3 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of IFITM3 mRNA CTD PMID:37019170 Ifitm3 Rat cisplatin decreases expression ISO IFITM3 (Homo sapiens) 6480464 Cisplatin results in decreased expression of IFITM3 mRNA CTD PMID:27392435 Ifitm3 Rat clofibrate multiple interactions ISO Ifitm3 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of IFITM3 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of IFITM3 mRNA] CTD PMID:17585979 Ifitm3 Rat clofibrate decreases expression ISO Ifitm3 (Mus musculus) 6480464 Clofibrate results in decreased expression of IFITM3 mRNA CTD PMID:17585979 Ifitm3 Rat cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of IFITM3 mRNA CTD PMID:24386269 Ifitm3 Rat copper atom multiple interactions ISO Ifitm3 (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of IFITM3 mRNA CTD PMID:15467011 Ifitm3 Rat copper(0) multiple interactions ISO Ifitm3 (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of IFITM3 mRNA CTD PMID:15467011 Ifitm3 Rat copper(II) chloride decreases expression ISO IFITM3 (Homo sapiens) 6480464 cupric chloride results in decreased expression of IFITM3 mRNA CTD PMID:38568856 Ifitm3 Rat Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of IFITM3 mRNA CTD PMID:26577399 Ifitm3 Rat cypermethrin increases expression ISO Ifitm3 (Mus musculus) 6480464 cypermethrin results in increased expression of IFITM3 mRNA CTD PMID:29020013 Ifitm3 Rat deguelin decreases expression ISO IFITM3 (Homo sapiens) 6480464 deguelin results in decreased expression of IFITM3 mRNA CTD PMID:33512557 Ifitm3 Rat deoxynivalenol decreases expression ISO IFITM3 (Homo sapiens) 6480464 deoxynivalenol results in decreased expression of IFITM3 protein CTD PMID:33890134 Ifitm3 Rat dexamethasone multiple interactions ISO IFITM3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of IFITM3 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of IFITM3 mRNA CTD PMID:28628672 Ifitm3 Rat dextran sulfate multiple interactions ISO Ifitm3 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of IFITM3 mRNA more ... CTD PMID:26271895 and PMID:32272095 Ifitm3 Rat dextran sulfate increases expression ISO Ifitm3 (Mus musculus) 6480464 Dextran Sulfate results in increased expression of IFITM3 protein CTD PMID:32272095 Ifitm3 Rat Di-n-octyl phthalate increases expression ISO Ifitm3 (Mus musculus) 6480464 di-n-octyl phthalate results in increased expression of IFITM3 mRNA CTD PMID:37810885 Ifitm3 Rat diarsenic trioxide increases expression ISO IFITM3 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of IFITM3 mRNA CTD PMID:20458559 Ifitm3 Rat dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of IFITM3 mRNA CTD PMID:21266533 Ifitm3 Rat diclofenac increases expression ISO Ifitm3 (Mus musculus) 6480464 Diclofenac results in increased expression of IFITM3 mRNA CTD PMID:26934552 Ifitm3 Rat dicrotophos increases expression ISO IFITM3 (Homo sapiens) 6480464 dicrotophos results in increased expression of IFITM3 mRNA CTD PMID:28302478 Ifitm3 Rat dieldrin decreases expression EXP 6480464 Dieldrin results in decreased expression of IFITM3 mRNA CTD PMID:34051100 Ifitm3 Rat diuron decreases expression EXP 6480464 Diuron results in decreased expression of IFITM3 mRNA CTD PMID:25152437 Ifitm3 Rat diuron increases expression EXP 6480464 Diuron metabolite results in increased expression of IFITM3 mRNA CTD PMID:24172598 Ifitm3 Rat dorsomorphin multiple interactions ISO IFITM3 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IFITM3 mRNA CTD PMID:27188386 Ifitm3 Rat elemental selenium increases expression ISO IFITM3 (Homo sapiens) 6480464 Selenium results in increased expression of IFITM3 mRNA CTD PMID:19244175 Ifitm3 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of IFITM3 mRNA CTD PMID:29391264 Ifitm3 Rat entinostat increases expression ISO IFITM3 (Homo sapiens) 6480464 entinostat results in increased expression of IFITM3 mRNA CTD PMID:26272509 Ifitm3 Rat entinostat multiple interactions ISO IFITM3 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IFITM3 mRNA CTD PMID:27188386 Ifitm3 Rat erlotinib hydrochloride decreases expression ISO IFITM3 (Homo sapiens) 6480464 Erlotinib Hydrochloride results in decreased expression of IFITM3 mRNA CTD PMID:27720938 Ifitm3 Rat fenthion increases expression ISO Ifitm3 (Mus musculus) 6480464 Fenthion results in increased expression of IFITM3 mRNA CTD PMID:34813904 Ifitm3 Rat finasteride decreases expression EXP 6480464 Finasteride results in decreased expression of IFITM3 mRNA CTD PMID:24136188 Ifitm3 Rat folic acid decreases expression ISO IFITM3 (Homo sapiens) 6480464 Folic Acid results in decreased expression of IFITM3 mRNA CTD PMID:11723236 Ifitm3 Rat folic acid multiple interactions ISO Ifitm3 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of IFITM3 mRNA] CTD PMID:22206623 Ifitm3 Rat folpet decreases expression ISO Ifitm3 (Mus musculus) 6480464 folpet results in decreased expression of IFITM3 mRNA CTD PMID:31558096 Ifitm3 Rat genistein decreases expression ISO IFITM3 (Homo sapiens) 6480464 Genistein results in decreased expression of IFITM3 mRNA CTD PMID:19371625 Ifitm3 Rat genistein decreases expression ISO Ifitm3 (Mus musculus) 6480464 Genistein results in decreased expression of IFITM3 mRNA CTD PMID:32186404 Ifitm3 Rat glafenine increases expression EXP 6480464 Glafenine results in increased expression of IFITM3 mRNA CTD PMID:24136188 Ifitm3 Rat hydrogen peroxide increases expression ISO Ifitm3 (Mus musculus) 6480464 Hydrogen Peroxide results in increased expression of IFITM3 mRNA CTD PMID:14729362 Ifitm3 Rat indometacin multiple interactions ISO IFITM3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of IFITM3 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of IFITM3 mRNA CTD PMID:28628672 Ifitm3 Rat irinotecan increases expression EXP 6480464 Irinotecan results in increased expression of IFITM3 mRNA CTD PMID:20097248 Ifitm3 Rat ivermectin decreases expression ISO IFITM3 (Homo sapiens) 6480464 Ivermectin results in decreased expression of IFITM3 protein CTD PMID:32959892 Ifitm3 Rat lead diacetate decreases expression ISO IFITM3 (Homo sapiens) 6480464 lead acetate results in decreased expression of IFITM3 mRNA CTD PMID:38568856 Ifitm3 Rat metformin decreases expression EXP 6480464 Metformin results in decreased expression of IFITM3 mRNA CTD PMID:31324951 Ifitm3 Rat methidathion increases expression ISO Ifitm3 (Mus musculus) 6480464 methidathion results in increased expression of IFITM3 mRNA CTD PMID:34813904 Ifitm3 Rat methotrexate decreases expression ISO IFITM3 (Homo sapiens) 6480464 Methotrexate results in decreased expression of IFITM3 mRNA CTD PMID:24449571 Ifitm3 Rat methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of IFITM3 mRNA CTD PMID:31378766 Ifitm3 Rat methylparaben decreases expression ISO IFITM3 (Homo sapiens) 6480464 methylparaben results in decreased expression of IFITM3 mRNA CTD PMID:38568856 Ifitm3 Rat N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of IFITM3 mRNA CTD PMID:28801915 Ifitm3 Rat nickel atom increases expression ISO IFITM3 (Homo sapiens) 6480464 Nickel results in increased expression of IFITM3 mRNA CTD PMID:24768652 and PMID:25583101 Ifitm3 Rat nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of IFITM3 mRNA CTD PMID:22110744 Ifitm3 Rat ochratoxin A increases expression ISO IFITM3 (Homo sapiens) 6480464 ochratoxin A results in increased expression of IFITM3 mRNA CTD PMID:29098329 Ifitm3 Rat ochratoxin A increases acetylation ISO IFITM3 (Homo sapiens) 6480464 ochratoxin A results in increased acetylation of IFITM3 promoter CTD PMID:29098329 Ifitm3 Rat ochratoxin A multiple interactions ISO IFITM3 (Homo sapiens) 6480464 [ochratoxin A results in increased acetylation of IFITM3 promoter] which results in increased expression of IFITM3 mRNA CTD PMID:29098329 Ifitm3 Rat oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of IFITM3 mRNA CTD PMID:25729387 Ifitm3 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IFITM3 mRNA CTD PMID:25729387 Ifitm3 Rat paracetamol decreases expression ISO IFITM3 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of IFITM3 mRNA CTD PMID:22230336 and PMID:29067470 Ifitm3 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of IFITM3 mRNA CTD PMID:33387578 Ifitm3 Rat paracetamol multiple interactions ISO Ifitm3 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of IFITM3 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of IFITM3 mRNA] CTD PMID:17585979 Ifitm3 Rat paraquat increases expression EXP 6480464 Paraquat results in increased expression of IFITM3 mRNA CTD PMID:32680482 Ifitm3 Rat pentachlorophenol increases expression ISO Ifitm3 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of IFITM3 mRNA CTD PMID:23892564 Ifitm3 Rat perfluorohexanesulfonic acid increases expression ISO Ifitm3 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of IFITM3 mRNA CTD PMID:37995155 Ifitm3 Rat perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of IFITM3 mRNA CTD PMID:19162173 Ifitm3 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Ifitm3 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IFITM3 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of IFITM3 mRNA CTD PMID:36331819 Ifitm3 Rat perfluorooctane-1-sulfonic acid increases expression ISO Ifitm3 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in increased expression of IFITM3 protein CTD PMID:26178269 Ifitm3 Rat perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of IFITM3 mRNA CTD PMID:19162173 Ifitm3 Rat phenformin increases expression EXP 6480464 Phenformin results in increased expression of IFITM3 mRNA CTD PMID:31324951 Ifitm3 Rat phenobarbital affects expression ISO IFITM3 (Homo sapiens) 6480464 Phenobarbital affects the expression of IFITM3 mRNA CTD PMID:19159669 Ifitm3 Rat picoxystrobin decreases expression ISO IFITM3 (Homo sapiens) 6480464 picoxystrobin results in decreased expression of IFITM3 mRNA CTD PMID:33512557 Ifitm3 Rat pirinixic acid multiple interactions ISO Ifitm3 (Mus musculus) 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of IFITM3 mRNA] CTD PMID:17950772 Ifitm3 Rat pirinixic acid decreases expression ISO Ifitm3 (Mus musculus) 6480464 pirinixic acid results in decreased expression of IFITM3 mRNA CTD PMID:17950772 and PMID:23811191 Ifitm3 Rat pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of IFITM3 mRNA CTD PMID:19162173 Ifitm3 Rat prothioconazole increases expression ISO IFITM3 (Homo sapiens) 6480464 prothioconazole results in increased expression of IFITM3 mRNA CTD PMID:35048155 Ifitm3 Rat resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of IFITM3 mRNA CTD PMID:19228061 Ifitm3 Rat resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of IFITM3 mRNA CTD PMID:25905778 Ifitm3 Rat rotenone increases expression EXP 6480464 Rotenone results in increased expression of IFITM3 mRNA CTD PMID:28374803 Ifitm3 Rat rotenone decreases expression ISO IFITM3 (Homo sapiens) 6480464 Rotenone results in decreased expression of IFITM3 mRNA CTD PMID:33512557 Ifitm3 Rat SB 431542 multiple interactions ISO IFITM3 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IFITM3 mRNA CTD PMID:27188386 Ifitm3 Rat selenium atom increases expression ISO IFITM3 (Homo sapiens) 6480464 Selenium results in increased expression of IFITM3 mRNA CTD PMID:19244175 Ifitm3 Rat silicon dioxide decreases expression ISO IFITM3 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of IFITM3 mRNA CTD PMID:25895662 Ifitm3 Rat silver atom decreases expression ISO Ifitm3 (Mus musculus) 6480464 Silver results in decreased expression of IFITM3 mRNA CTD PMID:27131904 Ifitm3 Rat silver(0) decreases expression ISO Ifitm3 (Mus musculus) 6480464 Silver results in decreased expression of IFITM3 mRNA CTD PMID:27131904 Ifitm3 Rat sodium arsenite decreases expression ISO IFITM3 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of IFITM3 mRNA CTD PMID:12727804 and PMID:38568856 Ifitm3 Rat sodium arsenite decreases expression ISO Ifitm3 (Mus musculus) 6480464 sodium arsenite results in decreased expression of IFITM3 mRNA CTD PMID:36209798 Ifitm3 Rat sodium dichromate decreases expression ISO Ifitm3 (Mus musculus) 6480464 sodium bichromate results in decreased expression of IFITM3 mRNA CTD PMID:31558096 Ifitm3 Rat Soman increases expression EXP 6480464 Soman results in increased expression of IFITM3 mRNA CTD PMID:19281266 Ifitm3 Rat streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of IFITM3 mRNA CTD PMID:25905778 Ifitm3 Rat sulforaphane decreases expression ISO IFITM3 (Homo sapiens) 6480464 sulforaphane results in decreased expression of IFITM3 mRNA CTD PMID:31838189 Ifitm3 Rat sulindac decreases expression EXP 6480464 Sulindac results in decreased expression of IFITM3 mRNA CTD PMID:24136188 Ifitm3 Rat sulindac sulfide decreases expression ISO IFITM3 (Homo sapiens) 6480464 sulindac sulfide results in decreased expression of IFITM3 mRNA CTD PMID:16184548 Ifitm3 Rat sunitinib decreases expression ISO IFITM3 (Homo sapiens) 6480464 Sunitinib results in decreased expression of IFITM3 mRNA CTD PMID:31533062 Ifitm3 Rat temozolomide increases expression ISO IFITM3 (Homo sapiens) 6480464 Temozolomide results in increased expression of IFITM3 mRNA CTD PMID:31758290 Ifitm3 Rat tert-butyl hydroperoxide increases expression ISO Ifitm3 (Mus musculus) 6480464 tert-Butylhydroperoxide results in increased expression of IFITM3 mRNA CTD PMID:14729362 and PMID:15003993 Ifitm3 Rat tetrachloromethane affects expression ISO Ifitm3 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of IFITM3 mRNA CTD PMID:17484886 Ifitm3 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of IFITM3 mRNA CTD PMID:31150632 Ifitm3 Rat thifluzamide decreases expression ISO IFITM3 (Homo sapiens) 6480464 thifluzamide results in decreased expression of IFITM3 mRNA CTD PMID:33512557 Ifitm3 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of IFITM3 mRNA CTD PMID:34492290 Ifitm3 Rat thiram decreases expression ISO IFITM3 (Homo sapiens) 6480464 Thiram results in decreased expression of IFITM3 mRNA CTD PMID:38568856 Ifitm3 Rat titanium dioxide increases expression ISO Ifitm3 (Mus musculus) 6480464 titanium dioxide results in increased expression of IFITM3 mRNA CTD PMID:23557971 Ifitm3 Rat topotecan increases expression EXP 6480464 Topotecan results in increased expression of IFITM3 mRNA CTD PMID:25729387 Ifitm3 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IFITM3 mRNA CTD PMID:25729387 Ifitm3 Rat tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of IFITM3 mRNA CTD PMID:21683754 Ifitm3 Rat Tributyltin oxide increases expression ISO Ifitm3 (Mus musculus) 6480464 bis(tri-n-butyltin)oxide results in increased expression of IFITM3 mRNA CTD PMID:18958704 Ifitm3 Rat triclosan increases expression ISO IFITM3 (Homo sapiens) 6480464 Triclosan results in increased expression of IFITM3 mRNA CTD PMID:30510588 Ifitm3 Rat triphenyl phosphate affects expression ISO IFITM3 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of IFITM3 mRNA CTD PMID:37042841 Ifitm3 Rat trovafloxacin increases expression ISO Ifitm3 (Mus musculus) 6480464 trovafloxacin results in increased expression of IFITM3 mRNA CTD PMID:35537566 Ifitm3 Rat tungsten decreases expression ISO Ifitm3 (Mus musculus) 6480464 Tungsten results in decreased expression of IFITM3 mRNA CTD PMID:30912803 Ifitm3 Rat valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of IFITM3 mRNA CTD PMID:24136188 Ifitm3 Rat valproic acid decreases expression ISO IFITM3 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of IFITM3 mRNA CTD PMID:23179753 Ifitm3 Rat valproic acid increases expression ISO IFITM3 (Homo sapiens) 6480464 Valproic Acid results in increased expression of IFITM3 mRNA CTD PMID:24935251 and PMID:27188386 Ifitm3 Rat valproic acid increases expression ISO Ifitm3 (Mus musculus) 6480464 Valproic Acid results in increased expression of IFITM3 mRNA CTD PMID:24896083 Ifitm3 Rat valproic acid increases methylation ISO IFITM3 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of IFITM3 gene CTD PMID:29154799 Ifitm3 Rat vancomycin decreases expression ISO Ifitm3 (Mus musculus) 6480464 Vancomycin results in decreased expression of IFITM3 mRNA CTD PMID:18930951 Ifitm3 Rat vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of IFITM3 mRNA CTD PMID:19015723 Ifitm3 Rat vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of IFITM3 mRNA CTD PMID:23034163 Ifitm3 Rat vitamin E increases expression ISO IFITM3 (Homo sapiens) 6480464 Vitamin E results in increased expression of IFITM3 mRNA CTD PMID:19244175 Ifitm3 Rat zearalenone decreases expression ISO IFITM3 (Homo sapiens) 6480464 Zearalenone results in decreased expression of IFITM3 mRNA CTD PMID:19371625
(-)-epigallocatechin 3-gallate (ISO) (1->4)-beta-D-glucan (ISO) 1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 1-naphthyl isothiocyanate (EXP) 17alpha-ethynylestradiol (EXP) 17beta-estradiol (EXP,ISO) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4,6-trinitrobenzenesulfonic acid (ISO) 2,4-dibromophenyl 2,4,5-tribromophenyl ether (ISO) 3,4-dichloroaniline (EXP) 3-isobutyl-1-methyl-7H-xanthine (ISO) 3H-1,2-dithiole-3-thione (EXP) 4,4'-sulfonyldiphenol (ISO) 5-aza-2'-deoxycytidine (ISO) 6-propyl-2-thiouracil (EXP) acetamide (EXP) all-trans-retinoic acid (ISO) amitrole (EXP) ammonium chloride (EXP) antimycin A (ISO) antirheumatic drug (ISO) aristolochic acid A (ISO) arsenous acid (ISO) azoxystrobin (ISO) benzo[a]pyrene (ISO) benzoates (ISO) beta-naphthoflavone (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) cadmium atom (ISO) cadmium dichloride (EXP,ISO) captan (ISO) carbon nanotube (ISO) chlordecone (ISO) chloropicrin (ISO) chlorpyrifos (ISO) cisplatin (ISO) clofibrate (ISO) cobalt dichloride (EXP) copper atom (ISO) copper(0) (ISO) copper(II) chloride (ISO) Cuprizon (EXP) cypermethrin (ISO) deguelin (ISO) deoxynivalenol (ISO) dexamethasone (ISO) dextran sulfate (ISO) Di-n-octyl phthalate (ISO) diarsenic trioxide (ISO) dibutyl phthalate (EXP) diclofenac (ISO) dicrotophos (ISO) dieldrin (EXP) diuron (EXP) dorsomorphin (ISO) elemental selenium (ISO) endosulfan (EXP) entinostat (ISO) erlotinib hydrochloride (ISO) fenthion (ISO) finasteride (EXP) folic acid (ISO) folpet (ISO) genistein (ISO) glafenine (EXP) hydrogen peroxide (ISO) indometacin (ISO) irinotecan (EXP) ivermectin (ISO) lead diacetate (ISO) metformin (EXP) methidathion (ISO) methotrexate (ISO) methylmercury chloride (EXP) methylparaben (ISO) N-methyl-4-phenylpyridinium (EXP) nickel atom (ISO) nickel dichloride (EXP) ochratoxin A (ISO) oxaliplatin (EXP) paracetamol (EXP,ISO) paraquat (EXP) pentachlorophenol (ISO) perfluorohexanesulfonic acid (ISO) perfluorooctane-1-sulfonic acid (EXP,ISO) perfluorooctanoic acid (EXP) phenformin (EXP) phenobarbital (ISO) picoxystrobin (ISO) pirinixic acid (EXP,ISO) prothioconazole (ISO) resveratrol (EXP) rotenone (EXP,ISO) SB 431542 (ISO) selenium atom (ISO) silicon dioxide (ISO) silver atom (ISO) silver(0) (ISO) sodium arsenite (ISO) sodium dichromate (ISO) Soman (EXP) streptozocin (EXP) sulforaphane (ISO) sulindac (EXP) sulindac sulfide (ISO) sunitinib (ISO) temozolomide (ISO) tert-butyl hydroperoxide (ISO) tetrachloromethane (EXP,ISO) thifluzamide (ISO) thioacetamide (EXP) thiram (ISO) titanium dioxide (ISO) topotecan (EXP) tributylstannane (EXP) Tributyltin oxide (ISO) triclosan (ISO) triphenyl phosphate (ISO) trovafloxacin (ISO) tungsten (ISO) valdecoxib (EXP) valproic acid (ISO) vancomycin (ISO) vinclozolin (EXP) vitamin E (ISO) zearalenone (ISO)
Ifitm3 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 205,540,649 - 205,541,758 (-) NCBI GRCr8 mRatBN7.2 1 196,111,026 - 196,112,135 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 196,111,043 - 196,112,203 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 1 204,456,782 - 204,457,903 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 1 211,583,367 - 211,584,488 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 1 204,257,495 - 204,258,616 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 1 213,810,712 - 213,811,821 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 213,810,696 - 213,811,901 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 220,730,715 - 220,731,824 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 201,198,659 - 201,199,768 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 1 193,745,524 - 193,746,633 (-) NCBI Celera Cytogenetic Map 1 q41 NCBI
IFITM3 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 11 319,676 - 320,860 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 11 319,676 - 329,475 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 11 319,676 - 320,860 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 11 309,673 - 310,914 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 11 309,668 - 311,050 NCBI Cytogenetic Map 11 p15.5 NCBI HuRef 11 137,979 - 139,220 (-) NCBI HuRef CHM1_1 11 318,636 - 319,877 (-) NCBI CHM1_1 T2T-CHM13v2.0 11 360,910 - 362,094 (-) NCBI T2T-CHM13v2.0
Ifitm3 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 7 140,589,503 - 140,590,657 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 7 140,589,499 - 140,590,683 (-) Ensembl GRCm39 Ensembl GRCm38 7 141,009,590 - 141,010,744 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 7 141,009,586 - 141,010,770 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 7 148,195,489 - 148,196,643 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 7 140,860,910 - 140,862,064 (-) NCBI MGSCv36 mm8 Celera 7 140,802,289 - 140,803,443 (-) NCBI Celera Cytogenetic Map 7 F5 NCBI cM Map 7 86.25 NCBI
LOC475935 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 18 25,484,731 - 25,485,927 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 18 25,134,337 - 25,135,526 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 18 26,068,903 - 26,070,152 (+) NCBI ROS_Cfam_1.0 UMICH_Zoey_3.1 18 25,579,473 - 25,580,663 (+) NCBI UMICH_Zoey_3.1 UU_Cfam_GSD_1.0 18 25,836,658 - 25,837,846 (+) NCBI UU_Cfam_GSD_1.0
LOC103238550
.
Predicted Target Of
Count of predictions: 88 Count of miRNA genes: 75 Interacting mature miRNAs: 77 Transcripts: ENSRNOT00000020265 Prediction methods: Microtar, Miranda, Rnahybrid Result types: miRGate_prediction
1578778 Pur4 Proteinuria QTL 4 3.3 0.003 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 1 150700247 252085048 Rat 1354646 Kidm18 Kidney mass QTL 18 5.7 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 1 151162512 256448636 Rat 1578780 Cm52 Cardiac mass QTL 52 3.3 0.0001 heart mass (VT:0007028) heart wet weight (CMO:0000069) 1 81591954 219808434 Rat 1354652 Kidm20 Kidney mass QTL 20 4.3 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 1 177227632 256448636 Rat 2302378 Insul11 Insulin level QTL 11 3.25 blood insulin amount (VT:0001560) serum insulin level (CMO:0000358) 1 144267353 251128347 Rat 1354653 Despr9 Despair related QTL 9 0.00019 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 1 167909849 212909849 Rat 2293673 Bss27 Bone structure and strength QTL 27 18.63 0.0001 femur morphology trait (VT:0000559) femur midshaft cortical cross-sectional area (CMO:0001663) 1 171629477 216629477 Rat 2293677 Bss41 Bone structure and strength QTL 41 9.38 0.0001 lumbar vertebra size trait (VT:0010518) lumbar vertebra cross-sectional area (CMO:0001689) 1 171629477 216629477 Rat 1302787 Stl25 Serum triglyceride level QTL 25 2.7 0.0073 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 1 180359209 210702199 Rat 70160 Bw18 Body weight QTL 18 5.7 body mass (VT:0001259) body weight (CMO:0000012) 1 144267353 196383668 Rat 1549830 Bss1 Bone structure and strength QTL 1 4.8 femur strength trait (VT:0010010) femur ultimate force (CMO:0001675) 1 172609619 217609619 Rat 7794788 Mcs32 Mammary carcinoma susceptibility QTL 32 2.61 mammary gland integrity trait (VT:0010552) mammary tumor incidence/prevalence measurement (CMO:0000946) 1 115540693 238914717 Rat 70163 Bw20 Body weight QTL 20 5.1 body mass (VT:0001259) body weight (CMO:0000012) 1 174133260 219133260 Rat 1578763 Kidm29 Kidney mass QTL 29 3.3 0.0001 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 1 179567751 260522016 Rat 1600395 Niddm69 Non-insulin dependent diabetes mellitus QTL 69 4.14 0.0002 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 1 195804352 257091168 Rat 1354624 Cm35 Cardiac mass QTL35 5.7 heart left ventricle mass (VT:0007031) calculated heart weight (CMO:0000073) 1 177227632 256448636 Rat 1600396 Niddm68 Non-insulin dependent diabetes mellitus QTL 68 4.97 0.0003 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 1 195804352 257091168 Rat 1558658 Bw59 Body weight QTL 59 3.5 0.0003 body mass (VT:0001259) body weight (CMO:0000012) 1 178784622 223784622 Rat 631838 Niddm36 Non-insulin dependent diabetes mellitus QTL 36 0.01 insulin secretion trait (VT:0003564) calculated pancreatic islet insulin release measurement (CMO:0001217) 1 184550676 229550676 Rat 1354636 Lmblg1 Limb length QTL 1 6.4 tibia length (VT:0004357) tibia length (CMO:0000450) 1 151162512 201278233 Rat 1549837 Hcar15 Hepatocarcinoma resistance QTL 15 0.05 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 1 153136852 260522016 Rat 2293689 Bss47 Bone structure and strength QTL 47 7.25 0.0001 lumbar vertebra size trait (VT:0010518) lumbar vertebra trabecular cross-sectional area (CMO:0001692) 1 171629477 216629477 Rat 152025235 Bw194 Body weight QTL 194 4.86 body mass (VT:0001259) 1 123556856 242907031 Rat 1600388 Niddm67 Non-insulin dependent diabetes mellitus QTL 67 5.84 0.000004 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 1 195804352 257091168 Rat 1598853 Memor3 Memory QTL 3 4.5 exploratory behavior trait (VT:0010471) total horizontal distance resulting from voluntary locomotion in an experimental apparatus (CMO:0001443) 1 143506580 212458660 Rat 61341 Bp26 Blood pressure QTL 26 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 169537671 214537671 Rat 1354634 Kidm12 Kidney mass QTL 12 3.9 kidney mass (VT:0002707) right kidney wet weight (CMO:0000082) 1 151162512 201278233 Rat 4889428 Stresp24 Stress response QTL 24 0.05 heart pumping trait (VT:2000009) absolute change in electrocardiographic low frequency R-R spectral component to high frequency R-R spectral component ratio (CMO:0002162) 1 155866514 200866514 Rat 152025232 Bw192 Body weight QTL 192 3.93 body mass (VT:0001259) 1 117917486 196963478 Rat 1578759 Uae30 Urinary albumin excretion QTL 30 3.3 0.003 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 150700247 252085048 Rat 61343 Bp28 Blood pressure QTL 28 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 151646613 196646613 Rat 2293693 Bss22 Bone structure and strength QTL 22 33.52 0.0001 femur morphology trait (VT:0000559) femur cross-sectional area (CMO:0001661) 1 171629477 216629477 Rat 2300161 Bmd43 Bone mineral density QTL 43 8.4 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 1 171629477 216629477 Rat 1300145 Rf7 Renal function QTL 7 2.96 urine creatinine amount (VT:0010540) urine creatinine level (CMO:0000125) 1 185145134 221264292 Rat 61347 Bp197 Blood pressure QTL 197 4.2 arterial blood pressure trait (VT:2000000) blood pressure measurement (CMO:0000003) 1 158633083 203633083 Rat 8655655 Arrd2 Age-related retinal degeneration QTL 2 7.79 retinal layer morphology trait (VT:0003727) percentage of study population developing retinopathy during a period of time (CMO:0002453) 1 183970203 243914901 Rat 61348 Bp30 Blood pressure QTL 30 2.4 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 144017057 197814409 Rat 2303622 Vencon6 Ventilatory control QTL 6 0.001 respiration trait (VT:0001943) respiration rate (CMO:0000289) 1 154561505 199561505 Rat 1358898 Bp255 Blood pressure QTL 255 3.6 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 191019702 246062233 Rat 631214 Bw61 Body weight QTL61 3.4 0.0001 intramuscular adipose amount (VT:0010044) intramuscular fat area (CMO:0001162) 1 173108781 218108781 Rat 7771612 Cm80 Cardiac mass QTL 80 8.4 heart left ventricle mass (VT:0007031) heart left ventricle weight (CMO:0000776) 1 149448574 221264292 Rat 731168 Bp154 Blood pressure QTL 154 3.4 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 94642644 214537671 Rat 631205 Bp196 Blood pressure QTL 196 4 0.0001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 118944897 199050459 Rat 2300174 Bmd42 Bone mineral density QTL 42 8.4 0.0001 lumbar vertebra mineral mass (VT:0010511) bone mineral density (CMO:0001226) 1 171629477 216629477 Rat 737828 Hcas3 Hepatocarcinoma susceptibility QTL 3 4.9 liver integrity trait (VT:0010547) liver tumorous lesion volume to total liver volume ratio (CMO:0001082) 1 144267353 222987745 Rat 1331749 Hrtrt11 Heart rate QTL 11 2.973 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 1 94494440 198211706 Rat 1354661 Bw33 Body weight QTL 33 5.2 body mass (VT:0001259) body weight (CMO:0000012) 1 151162512 256448636 Rat 1358886 Bp260 Blood pressure QTL 260 3.67 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 151162766 225824951 Rat 737977 Bp160 Blood pressure QTL 160 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 181133855 226133855 Rat 2293654 Bss30 Bone structure and strength QTL 30 32.65 0.0001 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 1 171629477 216629477 Rat 724531 Uae5 Urinary albumin excretion QTL 5 4 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 1 150700142 252085212 Rat 2300187 Bmd41 Bone mineral density QTL 41 8.9 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 1 171629477 216629477 Rat 8552891 Epfw5 Epididymal fat weight QTL 5 4.4 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 1 193113876 238113876 Rat 1359018 Hrtrt20 Heart rate QTL 20 3.08 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 1 185356336 202902618 Rat 70209 Niddm23 Non-insulin dependent diabetes mellitus QTL 23 2.82 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 94494440 198324465 Rat 1354580 Scort1 Serum corticosterone level QTL 1 3.4 blood corticosterone amount (VT:0005345) blood corticosterone level (CMO:0001172) 1 156677124 256448636 Rat 634312 Bp143 Blood pressure QTL 143 3 0.0002 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 182623426 219932796 Rat 1358294 Bw37 Body weight QTL 37 5 0.000011 body mass (VT:0001259) body weight (CMO:0000012) 1 171310381 216310381 Rat 61378 Bp43 Blood pressure QTL 43 22.6 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 181746937 196383668 Rat 634314 Niddm44 Non-insulin dependent diabetes mellitus QTL 44 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 49393289 199050459 Rat 724559 Pancm1 Pancreatic morphology QTL 1 7.1 islet of Langerhans morphology trait (VT:0005215) pancreatic islet damage composite score (CMO:0001156) 1 181759564 214537555 Rat 2312420 Pur17 Proteinuria QTL 17 7.1 0.0001 urine protein amount (VT:0005160) urine total protein excretion rate (CMO:0000756) 1 156677124 218753816 Rat 10059600 Bp378 Blood pressure QTL 378 3.08 0.05 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 176869060 221869060 Rat 1354591 Cm36 Cardiac mass QTL 36 4.1 heart left ventricle mass (VT:0007031) calculated heart weight (CMO:0000073) 1 102813953 201278233 Rat 7421630 Bp362 Blood pressure QTL 362 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 118608292 241799120 Rat 10059597 Bp377 Blood pressure QTL 377 3.42 0.025 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 32737458 199368955 Rat 619613 Bp77 Blood pressure QTL 77 0.01 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 1 164747424 209747424 Rat 631260 Tcas2 Tongue tumor susceptibility QTL 2 4.93 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 1 192485903 199050587 Rat 619614 Bp78 Blood pressure QTL 78 0.001 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 1 169112897 197261052 Rat 2312564 Glom18 Glomerulus QTL 18 2.4 0.003 kidney glomerulus morphology trait (VT:0005325) index of glomerular damage (CMO:0001135) 1 185356336 231689108 Rat 634321 Hc1 Hypercalciuria QTL 1 2.91 urine calcium amount (VT:0002985) urine calcium excretion rate (CMO:0000763) 1 178810256 240830002 Rat 724562 Rends1 Renal damage susceptibility QTL 1 0.05 kidney glomerulus integrity trait (VT:0010546) index of glomerular damage (CMO:0001135) 1 169537671 214537671 Rat 2292222 Bp307 Blood pressure QTL 307 3.06 0.0014 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 164310393 213533942 Rat 2292220 Bp306 Blood pressure QTL 306 3.47 0.00087 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 164310393 243914901 Rat 10059590 Kidm44 Kidney mass QTL 44 3.42 0.025 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 1 191033875 236033875 Rat 1354615 Cm32 Cardiac mass QTL 32 5.2 heart left ventricle mass (VT:0007031) heart left ventricle wet weight (CMO:0000071) 1 102813953 201278233 Rat 1600380 Niddm70 Non-insulin dependent diabetes mellitus QTL 70 3.1 0.0008 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 1 176550523 221550523 Rat 1354610 Bw34 Body weight QTL 34 4.1 body mass (VT:0001259) body weight (CMO:0000012) 1 151162512 256448636 Rat 1582206 Kidm33 Kidney mass QTL 33 6.9 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 1 188377360 224054420 Rat 1354620 Kidm19 Kidney mass QTL 19 4 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 1 151162512 201278233 Rat 8655855 Arrd3 Age-related retinal degeneration QTL 3 3.07 lens clarity trait (VT:0001304) cataract incidence/prevalence measurement (CMO:0001585) 1 183970203 243914901 Rat 634338 Hcar4 Hepatocarcinoma resistance QTL 4 4.6 liver integrity trait (VT:0010547) liver tumorous lesion number to liver area ratio (CMO:0001210) 1 193422268 214537671 Rat 1354618 Kidm15 Kidney mass QTL 15 5 kidney mass (VT:0002707) left kidney wet weight (CMO:0000083) 1 156677124 201278233 Rat 6903303 Scl34 Serum cholesterol QTL 34 2.5 0.0033 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 1 180359209 218108781 Rat 6480780 Insul18 Insulin level QTL 18 4.11 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 1 189607473 200611765 Rat 152025212 Bw190 Body weight QTL 190 5.7 body mass (VT:0001259) 1 123556856 196963478 Rat 631549 Bp89 Blood pressure QTL 89 5.7 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 123350581 201284552 Rat 2293083 Iddm25 Insulin dependent diabetes mellitus QTL 25 4.18 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 181829673 224569684 Rat 1354606 Bp246 Blood pressure QTL 246 3.6 arterial blood pressure trait (VT:2000000) pulse pressure (CMO:0000292) 1 102813953 218753816 Rat 738032 Hcas5 Hepatocarcinoma susceptibility QTL 5 3.12 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 1 176426412 257976495 Rat 1358191 Ept10 Estrogen-induced pituitary tumorigenesis QTL 10 3.8 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 1 192825253 243914732 Rat 1354602 Bw35 Body weight QTL 35 12.2 body mass (VT:0001259) body weight (CMO:0000012) 1 151162512 201278233 Rat 631670 Iddm10 Insulin dependent diabetes mellitus QTL 10 1.9 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 1 174133260 196383668 Rat
D1Wox76
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 196,111,621 - 196,111,731 (+) MAPPER mRatBN7.2 Rnor_6.0 1 213,811,308 - 213,811,417 NCBI Rnor6.0 Rnor_5.0 1 220,731,311 - 220,731,420 UniSTS Rnor5.0 RGSC_v3.4 1 201,199,255 - 201,199,364 UniSTS RGSC3.4 Celera 1 193,746,120 - 193,746,229 UniSTS Cytogenetic Map 1 q41 UniSTS
BI286569
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 196,111,162 - 196,111,314 (+) MAPPER mRatBN7.2 Rnor_6.0 1 213,810,849 - 213,811,000 NCBI Rnor6.0 Rnor_5.0 1 220,730,852 - 220,731,003 UniSTS Rnor5.0 RGSC_v3.4 1 201,198,796 - 201,198,947 UniSTS RGSC3.4 Celera 1 193,745,661 - 193,745,812 UniSTS Cytogenetic Map 1 q41 UniSTS
RH130094
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 196,401,933 - 196,402,143 (-) MAPPER mRatBN7.2 mRatBN7.2 1 196,401,934 - 196,402,143 (+) MAPPER mRatBN7.2 Rnor_6.0 1 214,283,865 - 214,284,073 NCBI Rnor6.0 Rnor_6.0 1 213,812,550 - 213,812,758 NCBI Rnor6.0 Rnor_5.0 1 220,732,553 - 220,732,761 UniSTS Rnor5.0 Rnor_5.0 1 221,201,413 - 221,201,621 UniSTS Rnor5.0 RGSC_v3.4 1 201,491,166 - 201,491,374 UniSTS RGSC3.4 Celera 1 194,035,806 - 194,036,014 UniSTS RH 3.4 Map 1 1437.6 UniSTS Cytogenetic Map 1 q41 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000020265 ⟹ ENSRNOP00000020265
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 196,111,043 - 196,112,203 (-) Ensembl Rnor_6.0 Ensembl 1 213,810,696 - 213,811,901 (-) Ensembl
RefSeq Acc Id:
NM_001136124 ⟹ NP_001129596
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 205,540,649 - 205,541,758 (-) NCBI mRatBN7.2 1 196,111,026 - 196,112,135 (-) NCBI Rnor_6.0 1 213,810,712 - 213,811,821 (-) NCBI Rnor_5.0 1 220,730,715 - 220,731,824 (-) NCBI RGSC_v3.4 1 201,198,659 - 201,199,768 (-) RGD Celera 1 193,745,524 - 193,746,633 (-) RGD
Sequence:
ACAGAGCCACAGAACTCTCCATCCTCTACCTTTCGCTGCTGCTTTTGCTCGGTACCATGAACCACACTTCTCAAGCCTTCGTGAACGCTGCCACTGGGGGACAACCCCCAAACTACGAAAGAATCAAG
hide sequence
RefSeq Acc Id:
NP_001129596 ⟸ NM_001136124
- UniProtKB:
B5DER6 (UniProtKB/Swiss-Prot), P26376 (UniProtKB/Swiss-Prot)
- Sequence:
MNHTSQAFVNAATGGQPPNYERIKEEYEVSELGAPHGSASVRTTVINMPREVSVPDHVVWSLFNTLFMNFCCLGFIAYAYSVKSRDRKMVGDMTGAQAYASTAKCLNISSLVLSILMVIITIVTVVII
hide sequence
Ensembl Acc Id:
ENSRNOP00000020265 ⟸ ENSRNOT00000020265
RGD ID: 13690525 Promoter ID: EPDNEW_R1049 Type: initiation region Name: Ifitm3_1 Description: interferon induced transmembrane protein 3 SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 1 213,811,850 - 213,811,910 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2006-11-20
Ifitm3
interferon induced transmembrane protein 3
Symbol and Name status set to provisional
70820 PROVISIONAL
